Clinical Study of GT719 Injection for Recurrent/Refractory CD19 Positive Adult B-cell Malignancies

by palligoelme@gmail.com | Apr 29, 2025 | Clinical Trials

​ Conditions: Hematological Malignancy (Leukemia- Lymphoma) Interventions: Biological: GT719 Injection Sponsors: Grit Biotechnology Recruiting Conditions: Hematological Malignancy (Leukemia- Lymphoma) Interventions: Biological: GT719 Injection Sponsors: Grit...

Effects of a Nursing-led Communication Using Mobile Health Information in Breast Cancer Patients Undergoing Concurrent Chemotherapy

by palligoelme@gmail.com | Apr 29, 2025 | Clinical Trials

​ Conditions: Breast Cancer Early Stage Breast Cancer (Stage 1-3) Interventions: Other: nursing-led communication support; Other: Nursing routine treatment Sponsors: National Defense Medical Center, Taiwan Recruiting Conditions: Breast Cancer Early Stage Breast Cancer...

A Study to Investigate the Relative Bioavailability of 2 Different Formulations of AZD4144, the Effect of Food and Omeprazole on the Pharmacokinetics of AZD4144 in Healthy Participants

by palligoelme@gmail.com | Apr 28, 2025 | Clinical Trials

​ Conditions: Healthy Participants Interventions: Drug: AZD4144; Drug: Omeprazole Sponsors: AstraZeneca; Parexel Not yet recruiting Conditions: Healthy Participants Interventions: Drug: AZD4144; Drug: Omeprazole Sponsors: AstraZeneca; Parexel Not yet...

Safety and Efficacy of AAV9/AP4B1 (BFB-101) For Patients With AP4B1-related Hereditary Spastic Paraplegia Type 47 (SPG47)

by palligoelme@gmail.com | Apr 28, 2025 | Clinical Trials

​ Conditions: HSP; Hereditary Spastic Paraplegia; Hereditary Spastic Paraparesis; Hereditary Spastic Paraplegia Type 50; Hereditary Spastic Paraplegia Type 47; Hereditary Spastic Paraplegia Type 51; Hereditary Spastic Paraplegia Type 52; SPG47; AP4B1; Neurogenetic...

Study of BLU-808 in Healthy Adult Participants

by palligoelme@gmail.com | Apr 28, 2025 | Clinical Trials

​ Conditions: Healthy Participants Interventions: Drug: BLU-808; Drug: Placebo; Drug: Midazolam Sponsors: Blueprint Medicines Corporation Completed Conditions: Healthy Participants Interventions: Drug: BLU-808; Drug: Placebo; Drug: Midazolam Sponsors: Blueprint...